MedTrace Logo

Different Level of ECSWT in Post Mastectomy Lymphedema

NCT06278298 · Status: ACTIVE_NOT_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 45

Last updated 2024-02-26

No results posted yet for this study

Summary

to investigate the effectiveness of different dosages of ECSW in the treatment of post mastectomy lymphedema volume and quality of life (Qol)

Conditions

  • Lymphedema of Upper Limb

Interventions

DEVICE

Shockwave

CDT and different dose of shockwave

OTHER

CDT

CDT

Sponsors & Collaborators

  • Cairo University

    lead OTHER

Principal Investigators

  • Haytham M Elhafez · faculty of physical therapy

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
30 Years
Max Age
60 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-03-01
Primary Completion
2024-06-01
Completion
2025-01-01

Countries

  • Egypt

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06278298 on ClinicalTrials.gov